Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Proquest Summons
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 30 | 13 | 4 | 7 |
Year wise citations received |
59 | 69 | 60 | 48 | 62 |
| Journal total citations count | 548 |
| Journal Impact Factor | 2.31 |
| Journal 5 years Impact Factor | 3.74 |
| Journal CiteScore | 4.86 |
| Journal h-index | 12 |
Important citations
Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19
Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
Role of dietary antioxidants in human metapneumovirus infection
nfectious mononucleosis and hepatic function
Oxidative stress and its association with covid-19: A narrative review
Anti?inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID?19 therapy
Vascular manifestations of COVID-19–thromboembolism and microvascular dysfunction
Flavonoids activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity
Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model
Up-regulation of nuclear factor E2-related factor 2 (Nrf2) represses the replication of SVCV
Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19
Can Activation of NRF2 Be a Strategy against COVID-19?
Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway
Redox Biology of Respiratory Viral Infections
Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
Morales-Vásquez, Lilliana, et al. "Demographics, clinical characteristics, IFNL3-and IFNL4-polymorphisms in a cohort of hepatitis C patients from Puerto Rico." Puerto Rico health sciences journal 33.4 (2014): 177.
Duconge, J. "Population heterogeneity and genomic admixture: relevance for global pharmacogenetics." J. Pharmacogenom. Pharmacoproteomics 5 (2014): 5.
Valentín, Isa I., et al. "Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans." Puerto Rico health sciences journal 33.3 (2014): 97.
Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.
Duconge, Jorge, et al. "A novel admixture-based pharmacogenetic approach to refine warfarin dosing in Caribbean Hispanics." PloS one 11.1 (2016): e0145480.